Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
about
Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@en
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@nl
type
label
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@en
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@nl
prefLabel
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@en
Preclinical studies using miR- ...... R-32-5p/TR4/HGF/Met signaling.
@nl
P2093
P2860
P356
P1476
Preclinical studies using miR- ...... iR-32-5p/TR4/HGF/Met signaling
@en
P2093
Dong-Rong Yang
Gonghui Li
Guosheng Yang
Jieyang Lu
Kefeng Wang
Mingchao Wang
P2860
P304
P356
10.1002/IJC.31289
P577
2018-04-02T00:00:00Z